SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yutaka Seino, Daisuke Yabe, Alogliptin benzoate for the treatment of type 2 diabetes, Expert Opinion on Pharmacotherapy, 2014, 15, 6, 851

    CrossRef

  2. 2
    L.G. Bowden, P.K. Maini, D.E. Moulton, J.B. Tang, X.T. Wang, P.Y. Liu, H.M. Byrne, An ordinary differential equation model for full thickness wounds and the effects of diabetes, Journal of Theoretical Biology, 2014, 361, 87

    CrossRef

  3. 3
    R. Brett McQueen, Samuel L. Ellis, David M. Maahs, Heather D. Anderson, Kavita V. Nair, Anne M. Libby, Jonathan D. Campbell, Association Between Glycated Hemoglobin and Health Utility for Type 1 Diabetes, The Patient - Patient-Centered Outcomes Research, 2014, 7, 2, 197

    CrossRef

  4. 4
    Jorge F. Elgart, Joaquín E. Caporale, Santiago Asteazarán, Jorge L. De La Fuente, Cecilia Camilluci, Jonathan B. Brown, Claudio D. González, Juan J. Gagliardino, Association between socioeconomic status, type 2 diabetes and its chronic complications in Argentina, Diabetes Research and Clinical Practice, 2014, 104, 2, 241

    CrossRef

  5. 5
    M. Evans, M. Wolden, J. Gundgaard, B. Chubb, T. Christensen, Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin – from the UK health care cost perspective, Diabetes, Obesity and Metabolism, 2014, 16, 4
  6. 6
    R. Sagarra, B. Costa, J.J. Cabré, O. Solà-Morales, F. Barrio, Coste-efectividad de la intervención sobre el estilo de vida para prevenir la diabetes tipo 2, Revista Clínica Española, 2014, 214, 2, 59

    CrossRef

  7. 7
    Joanna Leśniowska, Agata Schubert, Michał Wojna, Iwona Skrzekowska-Baran, Marta Fedyna, Costs of diabetes and its complications in Poland, The European Journal of Health Economics, 2014, 15, 6, 653

    CrossRef

  8. 8
    A. Calderón-Larrañaga, M. Soljak, E. Cecil, J. Valabhji, D. Bell, A. Prados Torres, A. Majeed, Does higher quality of primary healthcare reduce hospital admissions for diabetes complications? A national observational study, Diabetic Medicine, 2014, 31, 6
  9. 9
    P. Souto Barreto, C. Sanz, B. Vellas, M. Lapeyre-Mestre, Y. Rolland, Drug treatment for diabetes in nursing home residents, Diabetic Medicine, 2014, 31, 5
  10. 10
    Kamlesh Khunti, Xavier Cos, Guy Rutten, Insulin degludec – The impact of a new basal insulin on care in type 2 diabetes, Primary Care Diabetes, 2014, 8, 2, 119

    CrossRef

  11. 11
    R. Sagarra, B. Costa, J.J. Cabré, O. Solà-Morales, F. Barrio, Lifestyle interventions for diabetes mellitus type 2 prevention, Revista Clínica Española (English Edition), 2014, 214, 2, 59

    CrossRef

  12. 12
    Kate Wicks, Tanja Torbica, Kimberly A. Mace, Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound, Seminars in Immunology, 2014,

    CrossRef

  13. 13
    P. Aldam, N. Levy, G. M. Hall, Perioperative management of diabetic patients: new controversies, British Journal of Anaesthesia, 2014,

    CrossRef

  14. 14
    Silvia Paz, Diego González Segura, Anna Raya Torres, Luis Lizan, Principales factores asociados al coste de la diabetes mellitus tipo 2: revisión de la literatura, Avances en Diabetología, 2014, 30, 2, 34

    CrossRef

  15. 15
    Linda Ann Savas, Katherine Grady, Sarah Cotterill, Lucinda Summers, Ruth Boaden, J. Martin Gibson, Prioritising prevention: Implementation of IGT Care Call, a telephone based service for people at risk of developing type 2 diabetes, Primary Care Diabetes, 2014,

    CrossRef

  16. 16
    J. M. Khalid, M. Raluy-Callado, B. H. Curtis, K. S. Boye, A. Maguire, M. Reaney, Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics, International Journal of Clinical Practice, 2014, 68, 1
  17. 17
    Amélie Beaudet, John Clegg, Per-Olof Thuresson, Adam Lloyd, Phil McEwan, Review of Utility Values for Economic Modeling in Type 2 Diabetes, Value in Health, 2014, 17, 4, 462

    CrossRef

  18. 18
    Mary E. Costantino, Jane N. Stacy, Frank Song, Yihua Xu, Jonathan R. Bouchard, The Burden of Diabetes Mellitus for Medicare Beneficiaries, Population Health Management, 2014, 140527124346009

    CrossRef

  19. 19
    Clive Petry, Gestational Diabetes, 2014,

    CrossRef

  20. 20
    G. E. McVeigh, W. Gibson, P. K. Hamilton, Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease, Diabetes, Obesity and Metabolism, 2013, 15, 3
  21. 21
    Miglena Doneva, Vasil Valov, Anna-Maria Borisova, Tsvetalina Tankova, Alexandra Savova, Manoela Manova, Marcin Czech, Guenka Petrova, Comparative Analysis of the Cost of Insulin Treated Patients in Bulgaria, Biotechnology & Biotechnological Equipment, 2013, 27, 2, 3748

    CrossRef

  22. 22
    Gemma Rojo-Martínez, Sergio Valdés, Natalia Colomo, M. Isabel Lucena, Sonia Gaztambide, Ramón Gomis, Roser Casamitjana, Rafael Carmena, Miguel Catalá, María T. Martínez-Larrad, Manuel Serrano-Ríos, Luis Castaño, Joan Vendrell, Juan Girbés, Josep Franch, José A. Vázquez, Inmaculada Mora-Peces, Inés Urrutia, Gemma Pascual-Manich, Emilio Ortega, Edelmiro Menéndez, Elias Delgado, Elena Bordiú, Conxa Castell, Alfonso López-Alba, Alberto Goday, Alfonso Calle, Anna Bosch-Comas, Federico Soriguer, Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es, Revista Española de Cardiología, 2013, 66, 11, 854

    CrossRef

  23. 23
    G. Penno, A. Solini, E. Bonora, C. Fondelli, E. Orsi, G. Zerbini, R. Trevisan, M. Vedovato, G. Gruden, L. Laviola, A. Nicolucci, G. Pugliese, Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study, Journal of Internal Medicine, 2013, 274, 2
  24. 24
    A.H. Barnett, R. Brice, W. Hanif, J. James, H. Langerman, Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents, Current Medical Research and Opinion, 2013, 29, 11, 1503

    CrossRef

  25. 25
    Magnus Falk, Viktor Andoralov, Maria Silow, Miguel D. Toscano, Sergey Shleev, Miniature Biofuel Cell as a Potential Power Source for Glucose-Sensing Contact Lenses, Analytical Chemistry, 2013, 85, 13, 6342

    CrossRef

  26. 26
    MJ Taylor, TS Sahota, New technologies in insulin delivery, Practical Diabetes, 2013, 30, 1
  27. 27
    R. Waldeyer, R. Brinks, W. Rathmann, G. Giani, A. Icks, Projection of the burden of Type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040, Diabetic Medicine, 2013, 30, 8
  28. 28
    Torsten Lauritzen, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy EHM Rutten, Annelli Sandbæk, Rebecca K Simmons, Maureen van den Donk, Nicholas J Wareham, Simon J Griffin, Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?, Diabetes Management, 2013, 3, 5, 367

    CrossRef

  29. 29
    Gemma Rojo-Martínez, Sergio Valdés, Natalia Colomo, M. Isabel Lucena, Sonia Gaztambide, Ramón Gomis, Roser Casamitjana, Rafael Carmena, Miguel Catalá, María T. Martínez-Larrad, Manuel Serrano-Ríos, Luis Castaño, Joan Vendrell, Juan Girbés, Josep Franch, José A. Vázquez, Inmaculada Mora-Peces, Inés Urrutia, Gemma Pascual-Manich, Emilio Ortega, Edelmiro Menéndez, Elias Delgado, Elena Bordiú, Conxa Castell, Alfonso López-Alba, Alberto Goday, Alfonso Calle, Anna Bosch-Comas, Federico Soriguer, Use of Drugs Related to the Treatment of Diabetes Mellitus and Other Cardiovascular Risk Factors in the Spanish Population. The Di@bet.es Study, Revista Española de Cardiología (English Edition), 2013, 66, 11, 854

    CrossRef

  30. 30
    Tien-Jyun Chang, Yi-Der Jiang, Chia-Hsiun Chang, Ching-Hu Chung, Neng-Chun Yu, Lee-Ming Chuang, Accountability, utilization and providers for diabetes management in Taiwan, 2000–2009: An analysis of the National Health Insurance database, Journal of the Formosan Medical Association, 2012, 111, 11, 605

    CrossRef

  31. 31
    Eleanor Kennedy, David R Matthews, Do clinical research networks work? The NIHR diabetes research network after 6 years, Clinical Investigation, 2012, 2, 10, 971

    CrossRef

  32. 32
    James Jarrett, James Woodcock, Ulla K Griffiths, Zaid Chalabi, Phil Edwards, Ian Roberts, Andy Haines, Effect of increasing active travel in urban England and Wales on costs to the National Health Service, The Lancet, 2012, 379, 9832, 2198

    CrossRef

  33. 33
    Lynda M. Williams, Hypothalamic dysfunction in obesity, Proceedings of the Nutrition Society, 2012, 71, 04, 521

    CrossRef

  34. 34
    Eleanor D Kennedy, David R Matthews, NIHR Diabetes Research Network: the gold standard for clinical trials?, Practical Diabetes, 2012, 29, 8
  35. 35
    References,